English | Español
Jamie Barrand | Jan 6, 2016

FDA increases oversight of surgical mesh for transvaginal treatment
+ Technology/Innovation
Anna Aguillard | Jan 5, 2016

CMPI founder speaks out against biopharmaceutical price controls
+ Regulatory
Kerry Goff | Jan 5, 2016

AEI health care scholar stresses need for Medicare reform
+ Technology/Innovation
Katelyn Kivel | Jan 5, 2016

FDA fast-tracks 'breakthrough therapy' for cancer treatment
+ Technology/Innovation
Jamie Barrand | Jan 4, 2016

Pharmaceutical companies partner to research combination therapy for ovarian cancer
+ Regulatory
Jamie Barrand | Jan 2, 2016

Lawmakers approve Patient Access and Medicare Protection Act
+ Technology/Innovation
Jamie Barrand | Jan 2, 2016

Bristol-Myers Squibb sells HIV therapy portfolio to ViiV Healthcare
+ Regulatory
Jamie Barrand | Jan 2, 2016

Senate passes Preventing and Reducing Improper Medicare and Medicaid Expenditures Act

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes